These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18243516)

  • 41. Detrusorectomy reduces the need for augmentation and use of antimuscarinics in children with neuropathic bladders.
    Chrzan R; Dik P; Klijn AJ; Kuijper CF; de Jong TP
    J Pediatr Urol; 2013 Apr; 9(2):193-8. PubMed ID: 22364713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
    Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
    Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of solifenacin in patients with neurogenic detrusor overactivity as a result of spinal cord lesion.
    Krebs J; Pannek J
    Spinal Cord; 2013 Apr; 51(4):306-9. PubMed ID: 23247012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An artificial somatic-autonomic reflex pathway procedure for bladder control in children with spina bifida.
    Xiao CG; Du MX; Li B; Liu Z; Chen M; Chen ZH; Cheng P; Xue XN; Shapiro E; Lepor H
    J Urol; 2005 Jun; 173(6):2112-6. PubMed ID: 15879861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes in lower urinary tract function in children with hyperactive urinary bladder treated with combined therapy].
    Danilova TI; Medvedeva EV; Vasil'eva ZhB; Danilov VV
    Urologiia; 2007; (3):77-81. PubMed ID: 17722623
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
    Grosse J; Kramer G; Jakse G
    BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity.
    Lehtoranta K; Tainio H; Lukkari-Lax E; Hakonen T; Tammela TL
    Scand J Urol Nephrol; 2002 Feb; 36(1):18-24. PubMed ID: 12002352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study.
    Madersbacher H; Mürtz G; Alloussi S; Domurath B; Henne T; Körner I; Niedeggen A; Nounla J; Pannek J; Schulte-Baukloh H; Schultz-Lampel D; Bock P; Strugala G
    BJU Int; 2009 Mar; 103(6):776-81. PubMed ID: 19007380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity.
    Watanabe T; Yokoyama T; Sasaki K; Nozaki K; Ozawa H; Kumon H
    Int J Urol; 2004 Apr; 11(4):200-5. PubMed ID: 15028097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Editorial comment on: Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?
    Rembratt A
    Eur Urol; 2009 Mar; 55(3):719. PubMed ID: 18584945
    [No Abstract]   [Full Text] [Related]  

  • 51. Editorial comment on: Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?
    Porru D
    Eur Urol; 2009 Mar; 55(3):720. PubMed ID: 18584943
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term efficacy of tolterodine and patient compliance in pediatric patients with neurogenic detrusor overactivity.
    Christoph F; Moschkowitsch A; Kempkensteffen C; Schostak M; Miller K; Schrader M
    Urol Int; 2007; 79(1):55-9. PubMed ID: 17627170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
    Franco I; Horowitz M; Grady R; Adams RC; de Jong TP; Lindert K; Albrecht D
    J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Solifenacin in the treatment of patients with hyperactive urinary bladder].
    Al-Shukri SKh; Kuz'min IV
    Urologiia; 2007; (3):19-21. PubMed ID: 17722615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combinational effects of muscarinic receptor inhibition and β3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury.
    Wada N; Shimizu T; Takai S; Shimizu N; Tyagi P; Kakizaki H; Yoshimura N
    Neurourol Urodyn; 2017 Apr; 36(4):1039-1045. PubMed ID: 27367752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
    Kuo HC
    Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapy of bladder weakness].
    Wagenlehner FM
    Dtsch Med Wochenschr; 2005 Jan; 130(3):118. PubMed ID: 15650964
    [No Abstract]   [Full Text] [Related]  

  • 58. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A; Mearini E; Del Zingaro M; Porena M
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.
    Reitz A; Denys P; Fermanian C; Schurch B; Comperat E; Chartier-Kastler E
    Eur Urol; 2007 Dec; 52(6):1729-35. PubMed ID: 17884281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study.
    Lazzeri M; Calò G; Spinelli M; Guerrini R; Salvadori S; Beneforti P; Sandri S; Regoli D; Turini D
    Urology; 2003 May; 61(5):946-50. PubMed ID: 12736013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.